Fiscal Year (FY) 2020 Coronavirus Supplemental Funding (COVID-19) Example of Allowable Uses of Funds

This is a list of activities and purchases that may support your efforts to prepare for, prevent, and respond to coronavirus disease 2019 (COVID-19). This list is not exhaustive, as there may be other allowable uses of funds consistent with the terms and conditions of the award. The list is organized into three categories that correspond to the purpose of the award, with a description of each to provide general guidance. Many COVID-19 activities and uses of funds could fit within more than one category.

Testing, including temporary drive- or walk-up testing and laboratory services is a paramount need in many communities and HRSA encourages health centers to leverage this funding to expand health center COVID screening and testing capacity, consistent with CDC guidance for health care professionals and federal, state, territorial, and local public health recommendations.

All activities supported by COVID-19 funding must align with your Health Center Program scope of project and focus on COVID-19 prevention, preparedness, and/or response. If you require scope changes to prevent, prepare for, and/or respond to COVID-19 needs, review the technical assistance materials on the Scope of Project webpage and submit any needed scope adjustment or change in scope requests.

Prevent—Promote individual and community-wide prevention practices and/or administer countermeasures to reduce risk of COVID-19

Prepare—Enhance readiness and training to respond to COVID-19

  • Review, update, and/or implement your emergency operations plan, including plans to address surge capacity and potential provider and other health center staff absenteeism.
  • Hire and/or contract with new providers and/or other personnel to support increased service demand due to COVID-19.
  • Refresh training for all staff on standard, contact, and airborne precautions, and infection control procedures, including administrative rules and engineering controls, environmental hygiene, and appropriate use of personal protective equipment. Health centers may consider using the Centers for Disease Control and Prevention’s (CDC) pre-pandemic training HRSA BPHC exit disclaimer for influenza, which is recommended for COVID-19.
  • Strengthen partnerships with local and state public health authorities, and clinical and community-based organizations.
  • Review your infection control plan and make necessary adjustments to align with CDC Guidelines for Environmental Infection Control in Health-Care Facilities (PDF - 1.1 MB).
  • Create new and enhance existing preparedness and response workflows to embed CDC guidelines and recommendations, which may require role/task reassignment.
  • Train staff, establish workflows, and designate separate space to screen patients prior to entering communal areas of the health center so that those who may be infected with COVID-19 can be isolated.
  • Train staff, establish workflows, and designate separate space for clinical and administrative services for persons under investigation and those testing positive, including temporary and non-fixed barriers.
  • Enhance partnerships with medical respite facilities and other organizations delivering services to unsheltered individuals and/or prepare for expansion of or increased need for reliance on health center-supported respite care.
  • Embed CDC guidance into electronic health records (EHRs) clinical decision support tools.
  • Enhance website and social media feeds to include patient self-assessment tools and facilitate access to telemedicine visits.
  • Enhance telemedicine infrastructure to optimize virtual care, including increased capacity to assess persons with symptoms.
  • Enhance health information exchange capacity to support communications with public health partners, centralized assessment locations, and other health care providers, and/or to support transitions in care (e.g., to and from hospitals).

Respond—Assess, test, diagnose, treat, and limit spread of COVID-19

  • Support increased capacity for patient triage, testing (including drive- or walk-up testing) and laboratory services, and assessment of symptoms, including by telephone, text monitoring systems, or videoconference through extended operating hours, enhanced telephone triage capacity, digital applications, and additional providers and other personnel.
  • Enhance telehealth infrastructure to perform triage, care, and follow-up via telehealth, including with patients in community settings, with unstable or no housing, in homes, public housing, and other locations.
  • Enhance staffing and purchase equipment and supplies as necessary to deploy walk up testing and laboratory services locations and in-scope mobile units to provide testing and/or to deliver care.
  • Purchase a vehicle to transport patients to assessment and testing locations, and/or to transport health center personnel to deliver COVID-19 assessment and treatment.
  • Provide or otherwise support enhanced medical respite/recuperative care services.
  • Purchase supplies for respiratory hygiene and cough etiquette, including alcohol-based hand sanitizer that contains 60-95% alcohol, tissues, and no-touch receptacles for disposal.
  • Purchase personal protective equipment (PPE) for health center personnel and infected patients, including National Institute for Occupational Safety and Health (NIOSH)-approved N95 respirators for health center personnel.
  • Support COVID-19 testing and laboratory costs, including purchasing COVID-19 tests, specimen handling and collection, storage, and processing equipment, as appropriate.
  • Purchase and administer medical countermeasures that may be identified to lessen severity or length of COVID-19 illness.
Date Last Reviewed:  March 2020